Here, we present the case of a patient with myeloperoxidase-specific antineutrophil cytoplasmic antibody (MPO-ANCA) positive AAV who suffered from severe, transfusion-dependent anemia and advanced tubulointerstitial atrophy that was unresponsive to standard therapy. This evidence concerns the gene MPO and substance dependence.